{"pmid":32285689,"title":"Managing bioanalytical studies during the COVID-19 pandemic: an overview.","text":["Managing bioanalytical studies during the COVID-19 pandemic: an overview.","Bioanalysis","Pruim, Peter","Teekamp, Naomi","32285689"],"journal":"Bioanalysis","authors":["Pruim, Peter","Teekamp, Naomi"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32285689","week":"202016|Apr 13 - Apr 19","doi":"10.4155/bio-2020-0082","keywords":["COVID-19","GLP","bioanalysis","study management"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664071627103535104,"score":8.233237,"similar":[{"pmid":32134861,"title":"The outbreak of COVID-19: An overview.","text":["The outbreak of COVID-19: An overview.","In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%-5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms.","J Chin Med Assoc","Wu, Yi-Chi","Chen, Ching-Sung","Chan, Yu-Jiun","32134861"],"abstract":["In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%-5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms."],"journal":"J Chin Med Assoc","authors":["Wu, Yi-Chi","Chen, Ching-Sung","Chan, Yu-Jiun"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32134861","week":"202010|Mar 02 - Mar 08","doi":"10.1097/JCMA.0000000000000270","source":"PubMed","locations":["South Korea","Philippines","Wuhan","China","Thailand","Japan","United States","Viet Nam"],"countries":["United States","Japan","Thailand","Korea, Republic of","Philippines","China","Viet Nam"],"countries_codes":["USA|United States","JPN|Japan","THA|Thailand","KOR|Korea, Republic of","PHL|Philippines","CHN|China","VNM|Viet Nam"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1663352134210420736,"score":45.704685},{"pmid":32235685,"title":"COVID-19 Outbreak: An Overview on Dentistry.","text":["COVID-19 Outbreak: An Overview on Dentistry.","Coronavirus disease 2019, also called COVID-19, is the latest infectious disease to rapidly develop worldwide [...].","Int J Environ Res Public Health","Spagnuolo, Gianrico","De Vito, Danila","Rengo, Sandro","Tatullo, Marco","32235685"],"abstract":["Coronavirus disease 2019, also called COVID-19, is the latest infectious disease to rapidly develop worldwide [...]."],"journal":"Int J Environ Res Public Health","authors":["Spagnuolo, Gianrico","De Vito, Danila","Rengo, Sandro","Tatullo, Marco"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235685","week":"202014|Mar 30 - Apr 05","doi":"10.3390/ijerph17062094","keywords":["*COVID-19","*SARS-CoV-2","*coronavirus","*dentistry","*infection"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135461371904,"score":43.21325},{"pmid":32259829,"title":"COVID-19 Outbreak: An Overview.","text":["COVID-19 Outbreak: An Overview.","BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures.","Chemotherapy","Ciotti, Marco","Angeletti, Silvia","Minieri, Marilena","Giovannetti, Marta","Benvenuto, Domenico","Pascarella, Stefano","Sagnelli, Caterina","Bianchi, Martina","Bernardini, Sergio","Ciccozzi, Massimo","32259829"],"abstract":["BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures."],"journal":"Chemotherapy","authors":["Ciotti, Marco","Angeletti, Silvia","Minieri, Marilena","Giovannetti, Marta","Benvenuto, Domenico","Pascarella, Stefano","Sagnelli, Caterina","Bianchi, Martina","Bernardini, Sergio","Ciccozzi, Massimo"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259829","week":"202015|Apr 06 - Apr 12","doi":"10.1159/000507423","keywords":["COVID-19","Pandemic","Phylogenesis","Protein modeling","Real-time polymerase chain reaction","SARS-CoV-2"],"source":"PubMed","locations":["Wuhan","Hubei","Sarbecovirus","Wuhan-Hu-1","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1663450393427836928,"score":42.72272},{"pmid":32233034,"title":"Overview of guidance for endoscopy during the coronavirus disease 2019 (COVID-19) pandemic.","text":["Overview of guidance for endoscopy during the coronavirus disease 2019 (COVID-19) pandemic.","From its beginning in December 2019, the COVID-19 outbreak has spread globally from Wuhan and is now declared a pandemic by the World Health Organization (WHO). The sheer scale and severity of this pandemic is unprecedented in the modern era. Though primarily a respiratory tract infection transmitted by direct contact and droplets, during aerosol generating procedures (AGPs) there is a possibility of airborne transmission. In addition, emerging evidence suggests possible fecal-oral spread of the virus. Clinical departments that perform endoscopy are faced with daunting challenges during this pandemic. To date, multiple position statements and guidelines have been issued by various professional organizations to recommend practices in endoscopic procedures. This article aims to summarize and discuss available evidence for these practices, to provide guidance for endoscopy to enhance patient safety, avoid nosocomial outbreaks, protect healthcare personnel and ensure rational use of personal protective equipment (PPE). Responses adapted to national recommendations, local infection control guidelines and tailored to the availability of medical resources are imminently needed to fight the COVID-19 pandemic.","J Gastroenterol Hepatol","Lui, Rashid N","Wong, Sunny H","Sanchez-Luna, Sergio A","Pellino, Gianluca","Bollipo, Steven","Wong, Mei-Yin","Chiu, Philip Wy","Sung, Joseph Jy","32233034"],"abstract":["From its beginning in December 2019, the COVID-19 outbreak has spread globally from Wuhan and is now declared a pandemic by the World Health Organization (WHO). The sheer scale and severity of this pandemic is unprecedented in the modern era. Though primarily a respiratory tract infection transmitted by direct contact and droplets, during aerosol generating procedures (AGPs) there is a possibility of airborne transmission. In addition, emerging evidence suggests possible fecal-oral spread of the virus. Clinical departments that perform endoscopy are faced with daunting challenges during this pandemic. To date, multiple position statements and guidelines have been issued by various professional organizations to recommend practices in endoscopic procedures. This article aims to summarize and discuss available evidence for these practices, to provide guidance for endoscopy to enhance patient safety, avoid nosocomial outbreaks, protect healthcare personnel and ensure rational use of personal protective equipment (PPE). Responses adapted to national recommendations, local infection control guidelines and tailored to the availability of medical resources are imminently needed to fight the COVID-19 pandemic."],"journal":"J Gastroenterol Hepatol","authors":["Lui, Rashid N","Wong, Sunny H","Sanchez-Luna, Sergio A","Pellino, Gianluca","Bollipo, Steven","Wong, Mei-Yin","Chiu, Philip Wy","Sung, Joseph Jy"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233034","week":"202014|Mar 30 - Apr 05","doi":"10.1111/jgh.15053","source":"PubMed","locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352135384825858,"score":40.52684}]}